Pacific Smiles Group Limited (ASX:PSQ)
Australia · Delayed Price · Currency is AUD 2.180
-0.010 (-0.46%)
Oct 17, 2025, 4:10 PM AEST
Pacific Smiles Group Revenue
In the fiscal year ending June 30, 2025, Pacific Smiles Group had annual revenue of 196.05 million AUD with 8.74% growth. Pacific Smiles Group had revenue of 97.07 million in the half year ending June 30, 2025, with 14.26% growth.
Revenue
196.05M
Revenue Growth
+8.74%
P/S Ratio
1.80
Revenue / Employee
245.06K
Employees
800
Market Cap
352.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 196.05M | 15.75M | 8.74% |
| Jun 30, 2024 | 180.30M | 13.50M | 8.09% |
| Jun 30, 2023 | 166.80M | 27.02M | 19.33% |
| Jun 30, 2022 | 139.78M | -13.40M | -8.75% |
| Jun 30, 2021 | 153.18M | 33.12M | 27.59% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
Pacific Smiles Group News
- 8 months ago - Pacific Smiles Group Ltd (ASX:PSQ) H1 2025 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
- 8 months ago - Half Year 2025 Pacific Smiles Group Ltd Earnings Call Transcript - GuruFocus